Table 3 The expression of MUC2, MUC5AC, MUC6 and CDX2 in gastric cancer
Gastric cancer type | MUC2 | MUC5AC | MUC6 | CDX2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Positive cases (%) | Score a | Positive cases (%) | Score a | Positive cases (%) | Score a | Positive cases (%) | Score a | |||
Intestinal type | Total (45b) | 23 (51%)* | 3.24±0.49* | 23 (51%) | 3.47±0.53 | 18 (40%) | 2.22±0.42 | 30 (67%) | 3.20±0.39 | |
Differentiation | Well (14) | 10 (71%) | 4.57±0.85 | 7 (50%) | 3.36±0.96 | 5 (36%) | 2.07±0.79 | 11 (79%) | 4.00±0.69 | |
Moderate (11) | 4 (36%) | 2.09±0.88 | 7 (64%) | 4.27±1.05 | 5 (45%) | 2.36±0.82 | 6 (55%) | 2.27±0.73 | ||
Poor (20) | 9 (45%) | 2.95±0.77 | 9 (45%) | 3.10±0.81 | 8 (40%) | 2.25±0.64 | 13 (65%) | 3.15±0.61 | ||
Diffuse type (19) | 11 (58%) | 3.95±0.82 | 14 (74%) | 5.42±0.79 | 8 (42%) | 2.63±0.75 | 8 (42%) | 2.37±0.68 | ||
Mucinous type (6) | 6 (100%)* | 7.17±0.54* | 3 (50%) | 3.83±1.72 | 0 (0%) | 0±0 | 5 (83%) | 4.33±0.99 | ||
Total (70) | 40 (57%) | 3.77±0.41 | 40 (57%) | 4.03±0.43 | 26 (37%) | 2.14±0.34 | 43 (61%) | 3.07±0.33 | ||
